Carolyn Meredith, Gordon Tw Mander, Murray Thompson, Jessica Elliott, Lorraine Reynolds, Linda Ng
{"title":"探究地区和农村医疗服务中完全植入式血管通路设备故障的相关因素:一项回顾性病例对照研究。","authors":"Carolyn Meredith, Gordon Tw Mander, Murray Thompson, Jessica Elliott, Lorraine Reynolds, Linda Ng","doi":"10.1136/bmjoq-2024-002799","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The assessment and management of totally implanted vascular access devices (TIVAD) prior to the administration of medications/fluids are vital to ensuring the risk of harm is mitigated. While numerous guidelines exist for the insertion and management of TIVAD, the level of evidence and external validity to support these guidelines is lacking.</p><p><strong>Objectives: </strong>The purpose of this study was to identify factors associated with suboptimal TIVAD placement and with failure of TIVAD.</p><p><strong>Methods: </strong>A retrospective case-control study (n=80) was conducted at a regional hospital and health service in Australia. Binomial logistic regression analysis was performed using a backward selection approach to establish variables associated suboptimal TIVAD placement and with TIVAD failure.</p><p><strong>Findings: </strong>Significant associations were identified between the patient's primary diagnosis and suboptimal TIVAD insertion. Specifically, a prior diagnosis of breast cancer was associated with a decreased probability of optimal TIVAD tip placement (OR=0.236 (95% CI 0.058 to 0.960), p=0.044). A statistically significant association between TIVAD failure and the log of the heparinised saline flush rate and rate of undocumented flushes was also established. Further research is needed to identify and assess whether modification of these variables improves initial totally implantable venous access ports placement and risk of subsequent failure.</p>","PeriodicalId":9052,"journal":{"name":"BMJ Open Quality","volume":null,"pages":null},"PeriodicalIF":1.3000,"publicationDate":"2024-08-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11409290/pdf/","citationCount":"0","resultStr":"{\"title\":\"Exploring factors associated with failure of totally implanted vascular access devices in a regional and rural health service: a retrospective case-control study.\",\"authors\":\"Carolyn Meredith, Gordon Tw Mander, Murray Thompson, Jessica Elliott, Lorraine Reynolds, Linda Ng\",\"doi\":\"10.1136/bmjoq-2024-002799\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>The assessment and management of totally implanted vascular access devices (TIVAD) prior to the administration of medications/fluids are vital to ensuring the risk of harm is mitigated. While numerous guidelines exist for the insertion and management of TIVAD, the level of evidence and external validity to support these guidelines is lacking.</p><p><strong>Objectives: </strong>The purpose of this study was to identify factors associated with suboptimal TIVAD placement and with failure of TIVAD.</p><p><strong>Methods: </strong>A retrospective case-control study (n=80) was conducted at a regional hospital and health service in Australia. Binomial logistic regression analysis was performed using a backward selection approach to establish variables associated suboptimal TIVAD placement and with TIVAD failure.</p><p><strong>Findings: </strong>Significant associations were identified between the patient's primary diagnosis and suboptimal TIVAD insertion. Specifically, a prior diagnosis of breast cancer was associated with a decreased probability of optimal TIVAD tip placement (OR=0.236 (95% CI 0.058 to 0.960), p=0.044). A statistically significant association between TIVAD failure and the log of the heparinised saline flush rate and rate of undocumented flushes was also established. Further research is needed to identify and assess whether modification of these variables improves initial totally implantable venous access ports placement and risk of subsequent failure.</p>\",\"PeriodicalId\":9052,\"journal\":{\"name\":\"BMJ Open Quality\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":1.3000,\"publicationDate\":\"2024-08-07\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11409290/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"BMJ Open Quality\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1136/bmjoq-2024-002799\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"HEALTH CARE SCIENCES & SERVICES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMJ Open Quality","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/bmjoq-2024-002799","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0
摘要
背景:在使用药物/液体之前,对完全植入式血管通路装置(TIVAD)进行评估和管理对于确保降低伤害风险至关重要。虽然目前有许多关于 TIVAD 植入和管理的指南,但缺乏支持这些指南的证据和外部有效性:本研究旨在确定与 TIVAD 置入不理想和 TIVAD 失败相关的因素:方法:在澳大利亚的一家地区医院和医疗服务机构进行了一项回顾性病例对照研究(n=80)。采用逆向选择法进行了二项式逻辑回归分析,以确定与最佳TIVAD置入和TIVAD失败相关的变量:研究结果:发现患者的主要诊断与最佳TIVAD植入之间存在显著关联。具体而言,既往诊断为乳腺癌与最佳 TIVAD 尖端置入的概率降低有关(OR=0.236 (95% CI 0.058 to 0.960),P=0.044)。TIVAD失败与肝素化生理盐水冲洗率对数和无记录冲洗率之间也存在统计学意义上的重大关联。需要进行进一步研究,以确定和评估对这些变量的修改是否能改善最初的完全植入式静脉通路端口置入和随后的失败风险。
Exploring factors associated with failure of totally implanted vascular access devices in a regional and rural health service: a retrospective case-control study.
Background: The assessment and management of totally implanted vascular access devices (TIVAD) prior to the administration of medications/fluids are vital to ensuring the risk of harm is mitigated. While numerous guidelines exist for the insertion and management of TIVAD, the level of evidence and external validity to support these guidelines is lacking.
Objectives: The purpose of this study was to identify factors associated with suboptimal TIVAD placement and with failure of TIVAD.
Methods: A retrospective case-control study (n=80) was conducted at a regional hospital and health service in Australia. Binomial logistic regression analysis was performed using a backward selection approach to establish variables associated suboptimal TIVAD placement and with TIVAD failure.
Findings: Significant associations were identified between the patient's primary diagnosis and suboptimal TIVAD insertion. Specifically, a prior diagnosis of breast cancer was associated with a decreased probability of optimal TIVAD tip placement (OR=0.236 (95% CI 0.058 to 0.960), p=0.044). A statistically significant association between TIVAD failure and the log of the heparinised saline flush rate and rate of undocumented flushes was also established. Further research is needed to identify and assess whether modification of these variables improves initial totally implantable venous access ports placement and risk of subsequent failure.